Skip to main content

Table 1 Selected baseline characteristics of study participants

From: The effect of L-Carnitine supplementation on clinical symptoms, C-reactive protein and malondialdehyde in obese women with knee osteoarthritis: a double blind randomized controlled trial

 

L-carnitine group (n = 34)

Placebo group (n = 36)

Pa

Age (y)

55.01 ± 7.12

54.43 ± 7.80

0.737

BMI (kg/m2)

33.03 ± 6.67

32.10 ± 4.29

0.471

Height(m)

1.55 ± 0.10

1.56 ± 0.55

0.481

Weight (Kg)

78.69 ± 10.86

78.90 ± 12.17

0.937

Waist circumference (Cm)

105.13 ± 9.04

105.92 ± 10.57

0.728

Hip circumference (Cm)

115.63 ± 9.37

117.87 ± 10.56

0.332

Physical activity

548.01 ± 1131.4

540.01 ± 620.25

0.432

Energy (kcal)

1426.21 ± 344.91

1377.72 ± 406.44

0.577

Carbohydrate (g)

174.76 ± 37.21

177.38 ± 66.75

0.834

Fat (g)

60.83 ± 24.77

56.19 ± 27.55

0.443

Protein (g)

50.52 ± 19.34b

50.63 ± 22.17b

0.455

Education

 Illiterate

3 (7.9)

1 (2.6)

0.29

 Elementary school graduate

18 (47.4)

20 (52.6)

 

 Middle and high school graduate

13 (34.2)

14 (36.8)

 

 University graduate

4 (10.5)

3 (7.9)

 

Occupational status

  

0.42

 housewife

30 (78.9)

34 (89.5)

 

 employee

3 (13.9)

2 (5.3)

 

 Retired

5 (7.2)

2 (5.3)

 
  1. Mean ± SD (all such values except protein)
  2. aDetermined with the use of independent samples t tests for differences at baseline between L-carnitine and placebo groups
  3. bMedian and IQR (for no normally distributed variables)